JRS Pharma LP
Patterson, NY
- UEI
- HFDDN85DGS31
- CAGE
- 7UNT6
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 2981 NY-22 #1, Patterson, NY 12563, USA
- Website
- jrspharma.com
- Founded
- 1878
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $60,752 |
| FY2025 | $65,286 |
| FY2024 | $11,725 |
| FY2023 | $49,299 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $60,752 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Ferring Pharmaceuticals Inc. | Parsippany-Troy Hills, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Bryant Ranch Prepack | Burbank, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Accredo Health Group, Inc. | Memphis, TN | 456110 Pharmacies and Drug Retailers |
| Astor Drugs | Holtsville, NY | 325412 Pharmaceutical Preparation Manufacturing |
| Ascendis Pharma, Inc. | — | 325412 Pharmaceutical Preparation Manufacturing |
About the company
JRS Pharma LP is a for-profit pharmaceutical excipient manufacturer based in Patterson, New York, that has established itself as a specialized supplier to the federal government through contracts with the Department of Veterans Affairs. The company is registered with SAM.gov as a limited liability partnership and has maintained active federal contractor status since December 2016. JRS Pharma LP supplies pharmaceutical excipients—inactive ingredients critical to tablet formulation and drug delivery systems—that support the VA's healthcare operations and patient care programs across its medical facilities.
JRS Pharma LP has delivered PROSOLV EASYTAB SP, a pharmaceutical excipient product, through a series of delivery orders issued by the Department of Veterans Affairs Veterans Health Administration, specifically through Veterans Integrated Service Network 22. The company has fulfilled five distinct delivery orders spanning from December 2022 through the current contract period ending November 2026, with individual delivery order values ranging from $8,281.60 to $65,286.00. All awards have been firm fixed price delivery order contracts with no set-aside designations, reflecting competitive procurement practices. The delivery orders total $186,761.60 in cumulative contract value to date and represent a sustained procurement relationship, with JRS Pharma LP operating as an exclusive supplier within this service network. Performance of work has consistently occurred at the company's Patterson, New York facility, and no subcontractors or sub-award relationships have been identified in the contract documentation.
JRS Pharma LP holds a single-award Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network 22, effective December 1, 2022, through November 30, 2026, with a ceiling value of $247,009.80. This indefinite delivery vehicle was established to procure PROSOLV EASYTAB SP for supply to VA medical facilities within the service network region, ensuring reliable and continuous availability of this essential pharmaceutical component. The IDC structure allows the VA to issue delivery orders as needed while maintaining cost certainty through firm fixed pricing, and to date, four delivery orders totaling $186,761.60 have been issued against the $247,009.80 ceiling, leaving approximately $60,248.20 in remaining contract capacity. The contract demonstrates a strategic procurement arrangement designed to support patient care and treatment programs across the Veterans Health Administration by securing dependable supply chain management for specialized pharmaceutical excipients critical to VA healthcare operations.
Quick answers
Is JRS Pharma LP registered in SAM.gov?
Yes. JRS Pharma LP's SAM.gov registration is active through July 29, 2027.
What is JRS Pharma LP's CAGE code?
JRS Pharma LP's CAGE code is 7UNT6, and its Unique Entity ID (UEI) is HFDDN85DGS31.
How much has JRS Pharma LP received in federal contracts?
Federal contracts obligated $65,286 to JRS Pharma LP in fiscal year 2025 and $187,062 in fiscal years 2023 through 2027.
What is JRS Pharma LP's most recent federal award?
JRS Pharma LP's most recent federal contract award is Prosolv easytab SP OY2 (36C26226N0176), from Veterans Integrated Service Network 22 (VHA), on December 1, 2025.
On GovTribe
See JRS Pharma LP's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors